Julian Kaye, PhD

Researchers reported no association between endogenous testosterone and incident stroke and ischemic changes in men evaluated via brain MRI imaging.

Testosterone is not significantly associated with bone mineral density or fracture risk. Estrone, however, may have a role in bone health and fracture prevention in postmenopausal women.

To ensure that anaphylaxis episodes are treated in a timely and effective manner, action plans should be developed and distributed to patients, family and other caregivers, and schools.

A detailed presentation at AAP 2014 covered recent hot topics in antibiotic development, microbial resistance, pneumonia treatment, fluoroquinolone safety, and the impact of antibiotic use on the gut microbiome.

Atopic dermatitis is the most common inflammatory pediatric skin disorder, with reported incidences ranging from 10% to 20%. The principles of effect care include fixing the skin barrier, short-circuiting inflammation, decreasing itching, treating infections, and striving for prevention by addressing the triggers.

Results from two studies show that treatment with the novel kinase inhibitor nintedanib significantly slowed disease progression in patients with idiopathic pulmonary fibrosis (IPF). However, only one study showed nintedanib had any effect on slowing deterioration in quality of life or reducing the risk of a first acute exacerbation compared with placebo.

Successful applications of nanotechnology in the field of immunology will enable new generations of vaccines, adjuvants, and immunomodulatory drugs that aim to improve clinical outcomes in response in a range of infectious and non-infectious diseases.

With reimbursement increasingly tied to quality measures and other metrics, the question of whether best practices actually produce improved outcomes has taken on greater importance for clinicians and their patients.

New research suggests that patients with allergic rhinitis face significantly lower risks for heart attacks, cerebrovascular disease, and all-cause mortality.

While phenotypes of multiple sclerosis (MS) are well-established, there remains heterogeneity among patients that fit existing clinical definitions.

More than 90% of participants in the Therapy Optimization in Multiple Sclerosis (TOP MS) study were still on their original disease modifying therapy at one year follow-up.